Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10 Pt 1
|
pubmed:dateCreated |
1977-12-29
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0091-2700
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
569-78
|
pubmed:dateRevised |
2009-10-27
|
pubmed:meshHeading |
pubmed-meshheading:21199-Anti-Anxiety Agents,
pubmed-meshheading:21199-Dose-Response Relationship, Drug,
pubmed-meshheading:21199-Drug Evaluation,
pubmed-meshheading:21199-Flunitrazepam,
pubmed-meshheading:21199-Humans,
pubmed-meshheading:21199-Placebos,
pubmed-meshheading:21199-Sleep,
pubmed-meshheading:21199-Sleep Disorders,
pubmed-meshheading:21199-Sleep Stages
|
pubmed:year |
1977
|
pubmed:articleTitle |
Flunitrazepam, an investigational hypnotic drug: sleep laboratory evaluations.
|
pubmed:publicationType |
Journal Article
|